Tag: Apple CEO
Pancreatic Neuroendocrine Tumors: A Rare Cancer
From your next door neighbor to Steve Jobs, co-founder of Apple who just announced that he is stepping down as CEO of the company, pancreatic neuroendocrine tumors (pNETs) affect less than 1 person in 100,000 in the United States. This rare cancer is often…
READ MORE
Breaking News: Pancreatic NET Cancer Patient Steve Jobs Steps Down as CEO of Apple
On August 24, 2011, Steve Jobs, CEO of Apple, announced that he was stepping down from his position. In his letter to the Apple Board of Directors and the Apple Community, Mr. Jobs wrote, “I have always said if there ever came a day when I could no longer meet…
READ MORE
Carcinoid Cancer Foundation Thanks Steve Jobs for Bringing about Greater Awareness of Neuroendocrine Cancers
Since the announcement was made earlier this month that Apple’s CEO Steve Jobs would be taking a medical leave of absence there has been significant media coverage about pancreatic neuroendocrine tumors, NET cancer, and carcinoid. Although…
READ MORE
Steve Jobs to Take New Medical Leave from Apple
Steve Jobs, CEO and co-founder of Apple and the most well-known member of the carcinoid and neuroendocrine tumor community, is taking a new medical leave of absence. This announcement was reported today, January 17, 2011, by The New York Times, a year…
READ MORE
Steve Jobs, Pancreatic Neuroendocrine Tumor Patient, Talks about Liver Transplant
Steve Jobs, CEO of Apple, is the most well-known member of the carcinoid and neuroendocrine tumor community. He was diagnosed with an islet cell pancreatic neuroendocrine tumor (NET) in 2004 for which he had surgery, followed by a liver transplant in …
READ MORE
